전일 마감가:
$277.04
열려 있는:
$275.06
하루 거래량:
1.60M
Relative Volume:
0.84
시가총액:
$74.87B
수익:
$260.93B
순이익/손실:
$5.02B
주가수익비율:
15.31
EPS:
18.32
순현금흐름:
$3.94B
1주 성능:
+3.59%
1개월 성능:
-7.52%
6개월 성능:
-4.18%
1년 성능:
-14.52%
시그나 Stock (CI) Company Profile
명칭
Cigna Group
전화
(860) 226-6000
주소
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
CI을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
CI
Cigna Group
|
280.47 | 73.95B | 260.93B | 5.02B | 3.94B | 18.32 |
![]()
UNH
Unitedhealth Group Inc
|
261.57 | 228.94B | 422.82B | 21.30B | 25.27B | 23.08 |
![]()
CVS
Cvs Health Corp
|
65.51 | 82.29B | 386.64B | 4.53B | 4.78B | 3.58 |
![]()
ELV
Elevance Health Inc
|
292.48 | 65.48B | 189.25B | 5.36B | 5.34B | 23.50 |
![]()
HUM
Humana Inc
|
274.94 | 32.07B | 117.76B | 1.21B | 2.39B | 9.95 |
시그나 Stock (CI) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-02-06 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
2024-06-26 | 개시 | Piper Sandler | Overweight |
2024-05-30 | 개시 | Robert W. Baird | Outperform |
2024-03-06 | 개시 | Barclays | Overweight |
2024-02-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2024-02-05 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2024-02-01 | 업그레이드 | Deutsche Bank | Hold → Buy |
2024-01-04 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
2023-12-11 | 업그레이드 | Jefferies | Hold → Buy |
2023-08-18 | 다운그레이드 | Edward Jones | Buy → Hold |
2023-06-06 | 업그레이드 | BofA Securities | Neutral → Buy |
2023-04-21 | 개시 | Cantor Fitzgerald | Neutral |
2023-04-05 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2023-01-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2022-11-23 | 재개 | Morgan Stanley | Overweight |
2022-11-21 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
2022-07-14 | 다운그레이드 | Jefferies | Buy → Hold |
2022-06-22 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2022-06-17 | 개시 | Loop Capital | Hold |
2022-05-27 | 재개 | Bernstein | Mkt Perform |
2022-05-26 | 업그레이드 | BofA Securities | Underperform → Neutral |
2022-05-16 | 업그레이드 | JP Morgan | Neutral → Overweight |
2022-05-09 | 업그레이드 | Cowen | Market Perform → Outperform |
2022-02-07 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2022-02-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2022-01-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2021-12-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2021-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2021-12-14 | 개시 | Goldman | Neutral |
2021-11-17 | 개시 | Seaport Research Partners | Buy |
2021-09-27 | 개시 | SVB Leerink | Mkt Perform |
2021-09-10 | 다운그레이드 | BofA Securities | Buy → Underperform |
2021-09-10 | 개시 | Cowen | Market Perform |
2021-08-06 | 재확인 | BofA Securities | Buy |
2021-08-06 | 재확인 | Citigroup | Buy |
2021-08-06 | 재확인 | Deutsche Bank | Buy |
2021-08-06 | 재확인 | Jefferies | Buy |
2021-08-06 | 재확인 | Mizuho | Buy |
2021-08-06 | 재확인 | Oppenheimer | Outperform |
2021-08-06 | 재확인 | Truist | Buy |
2021-05-19 | 개시 | Wells Fargo | Equal Weight |
2020-07-01 | 개시 | SVB Leerink | Mkt Perform |
2020-05-04 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
2020-03-24 | 업그레이드 | Raymond James | Outperform → Strong Buy |
2019-12-11 | 다운그레이드 | Wells Fargo | Market Perform → Underperform |
2019-10-18 | 개시 | Mizuho | Buy |
2019-09-30 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
2019-09-12 | 개시 | Deutsche Bank | Buy |
2019-08-06 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
2019-04-23 | 개시 | UBS | Buy |
2019-01-14 | 개시 | Stephens | Overweight |
2018-12-24 | 개시 | Edward Jones | Buy |
2018-03-13 | 개시 | Bernstein | Mkt Perform |
2018-03-08 | 개시 | Barclays | Overweight |
2018-01-03 | 개시 | Goldman | Neutral |
2017-11-03 | 재확인 | RBC Capital Mkts | Outperform |
2017-06-22 | 재확인 | RBC Capital Mkts | Outperform |
2017-06-12 | 개시 | Credit Suisse | Outperform |
2017-06-07 | 개시 | Morgan Stanley | Overweight |
2017-05-08 | 재확인 | RBC Capital Mkts | Outperform |
2017-04-05 | 개시 | Deutsche Bank | Buy |
모두보기
시그나 주식(CI)의 최신 뉴스
How Aetna, Cigna, UnitedHealth stacked up in Q2 earnings - Modern Healthcare
What makes The Cigna Group stock price move sharplyHigh Impact Investment Signals - thegnnews.com
Earnings Surge and Major Buybacks Could Be a Game Changer for Cigna Group (CI) - simplywall.st
Integrated medical, dental, and behavioral health treatment can lead to better health outcomes - Cigna Healthcare Newsroom
Cigna (CI) Pullback a Buying Opportunity, Says TD Cowen with a Buy Rating - MSN
What Cigna Group (CI)'s Strong Q2 Earnings and Share Buyback Reveal About Shareholder Value - simplywall.st
A transformative journey across the Midwest: Suzan Brydon’s Community Ambassador Fellowship story - The Cigna Group Newsroom
1 Safe-and-Steady Stock to Target This Week and 2 We Avoid - TradingView
MARPAI TO HOST WEBCAST ON AUGUST 14, 2025 TO DISCUSS SECOND QUARTER 2025 FINANCIAL RESULTS - Benzinga
We Think Cigna Group's (NYSE:CI) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance
Cigna’s Growth Story Comes With Margin Worries Attached - Finimize
J.P. Morgan Maintains Cigna Group(CI.US) With Buy Rating, Announces Target Price $428 - 富途牛牛
Cigna vs. UnitedHealth Group: Why Cigna Offers a More Attractive Value-Driven Investment in the Health Care Providers & Services Sector - AInvest
Cigna: Looks More Interesting Here Than UnitedHealth Group (NYSE:CI) - Seeking Alpha
Wall Street sours on health insurance - Modern Healthcare
Bert Nash cancels its contract with insurer Cigna; 121 patients could be affected - Lawrence Journal-World
Cigna (CI) Surges 2.2% on Strategic Expansion and Analyst Optimism: Is This the Start of a Bullish Rebound? - AInvest
Does Cigna Group's (CI) Margin Pressure Challenge Its Long-Term Growth Narrative? - simplywall.st
Cigna Expands Flexible Dental Payment Solution to 2.8 Million More Members, Driving Increases in Preventive Care and Critical Procedures - AInvest
Skipping the Dentist? Not Anymore: Cigna Expands Access to Flexible Dental Payments, Driving Meaningful Increases in Preventive Care and Critical Procedures - Morningstar
Deutsche Bank Adjusts Cigna Group Price Target to $415 From $372, Maintains Buy Rating - MarketScreener
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes - MSN
Cigna's $660M Volume Falls 26.2% to 150th Market Rank as Shares Rise 1.66% on Strategic Shifts and Expanded Partnerships - AInvest
Elevated Medicare Advantage, ACA marketplace costs sting insurers in mixed Q2 - Fierce Healthcare
Guggenheim Maintains Cigna Group(CI.US) With Buy Rating, Cuts Target Price to $350 - 富途牛牛
Elite Investors see life in Cigna - Citywire
The Cigna Group Stock Analysis and ForecastCapitalize on momentum-driven opportunities - Jammu Links News
Is The Cigna Group a good long term investmentMaximize portfolio growth with strategic plans - Jammu Links News
Cigna Group's Q2 2025 Earnings: Balancing Long-Term Growth in Evernorth with Near-Term Profitability Pressures - AInvest
Cigna Group Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
What are analysts’ price targets for The Cigna Group in the next 12 monthsAccess powerful market insights for free - jammulinksnews.com
Cigna Group abandons seeking merger with Humana - 富途牛牛
The Cigna Group Beat Revenue Forecasts By 7.2%: Here's What Analysts Are Forecasting Next - Yahoo Finance
The Cigna Group Just Beat Revenue Estimates By 7.2% - 富途牛牛
A Quick Look at Today's Ratings for Cigna Group(CI.US), With a Forecast Between $336 to $390 - 富途牛牛
The Cigna (CI) Group Falls 10% as Earnings Disappoint - MSN
Cigna Stock Slides 8% On Thursday But Wells Fargo Analyst Is Surprised: Here’s What Happened - Stocktwits
Cigna Group Reports Strong Q2 2025 Earnings - The Globe and Mail
What institutional investors are buying The Cigna Group stockTop Growth Ideas For 2025 - Jammu Links News
Cigna's Q2 2025 Earnings: Can Strategic Growth Offset Profit Stagnation for Long-Term Investors? - AInvest
Cigna price target lowered to $375 from $405 at Truist - MSN
How strong is The Cigna Group company’s balance sheetTop Growth Entry Points For Every Investor - Jammu Links News
Cigna Plunges 3.33% Amid Earnings Volatility and Sector Turmoil – What’s Next for CI? - AInvest
Why Cigna (CI) is a Great Dividend Stock Right Now - Yahoo Finance
Cigna reaffirms 2025 adjusted EPS outlook of at least $29.60 while expanding specialty pharmacy growth - MSN
Cigna Group's Strategic Resilience: Navigating Stop-Loss Challenges in a High-Cost Healthcare Era - AInvest
Cigna Group's Balanced Play Keeps Analysts On Board - Finimize
Cigna stock hits 52-week low at 261.66 USD - Investing.com Australia
Cigna stock hits 52-week low at 261.66 USD By Investing.com - Investing.com India
Cigna beats investor expectations on Evernorth growth - Healthcare Dive
When is The Cigna Group stock expected to show significant growthPost Market Target Finder To Watch Now - Jammu Links News
시그나 (CI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):